Over the 90-day window ending February 07, 2026, Olema Pharmaceuticals's three dominant insider ownership positions are held by TenPercentOwner Capital Life Sciences Investors, Llc Bain (4.30Mn shares), Director Cyrus Harmon (844.80K shares), TenPercentOwner Biocapital Advisors Lp Paradigm (783.12K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Life Sciences Investors, Llc Bain | 4,300,000 | 13 Jan, 2025 | |
| Cyrus Harmon | 844,798 | 21 Jan, 2026 | |
| Biocapital Advisors Lp Paradigm | 783,118 | 05 Aug, 2024 | |
| G. Walmsley Graham | 700,761 | 18 Dec, 2024 | |
| David C. Myles | Ch. Discov. & Non Clin Dev Off | 687,607 | 14 Jan, 2026 |
| Partners L P/Il Bvf | 447,526 | 14 Jan, 2025 | |
| Andrew Rappaport | 385,965 | 25 Nov, 2025 | |
| Sean Bohen | President And Ceo | 237,650 | 30 Dec, 2025 |
| Shane William Charles Kovacs | Ch. Operating & Financial Off. | 139,727 | 15 Jan, 2026 |
| Naseem Zojwalla | Chief Medical Officer | 4,488 | 23 Dec, 2025 |
| Kinney Horn | Chief Business Officer | 2,458 | 14 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jan, 2026 | Cyrus Harmon | Common Stock | D | 10,000 | $26.88 | 727,770 | D | S |
| 15 Jan, 2026 | Shane William Charles Kovacs | Common Stock | D | 100,000 | $28.73 | 139,727 | D | S |
| 14 Jan, 2026 | David C. Myles | Common Stock | D | 14,997 | $28.60 | 577,764 | D | S |
| 14 Jan, 2026 | David C. Myles | Common Stock | D | 35,003 | $28.99 | 542,761 | D | S |
| 14 Jan, 2026 | David C. Myles | Common Stock | A | 50,000 | $4.87 | 592,761 | D | M |
| 14 Jan, 2026 | Cyrus Harmon | Common Stock | D | 3,489 | $29.12 | 737,770 | D | S |
| 13 Jan, 2026 | Shane William Charles Kovacs | Common Stock | D | 3,822 | $28.01 | 239,727 | D | S |
| 13 Jan, 2026 | David C. Myles | Common Stock | A | 50,000 | $4.87 | 592,761 | D | M |
| 13 Jan, 2026 | David C. Myles | Common Stock | D | 200 | $28.49 | 542,761 | D | S |
| 13 Jan, 2026 | David C. Myles | Common Stock | D | 49,800 | $27.60 | 542,961 | D | S |
| 12 Jan, 2026 | David C. Myles | Common Stock | D | 10,000 | $28.34 | 144,846 | I | S |
| 26 Dec, 2025 | Sean Bohen | - | - | 237,650 | D | |||
| 26 Dec, 2025 | Sean Bohen | Common Stock | D | 8,500 | $0.00 | 237,650 | D | G |
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | D | 99,509 | $27.66 | 4,488 | D | S |
| 23 Dec, 2025 | Naseem Zojwalla | - | - | 103,997 | D | |||
| 23 Dec, 2025 | Naseem Zojwalla | - | - | 4,488 | D | |||
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 50,000 | $7.02 | 103,997 | D | M |
| 22 Dec, 2025 | Cyrus Harmon | Common Stock | D | 2,881 | $28.53 | 741,259 | D | S |
| 22 Dec, 2025 | Naseem Zojwalla | - | - | 153,997 | D | |||
| 22 Dec, 2025 | Naseem Zojwalla | - | - | 146,815 | D |